Oncology

Tumor markers can help guide future treatments for patients with bladder cancer.

Top news of the week in oncology and cancer drug development.

Developed countries may be able to assist developing countries in ensuring their drugs are safe.

Top news of the day from across the health care landscape.

Testing method could improve radioembolization technique in cancer treatment.

Newly-discovered compound blocks an essential protein in sustaining tumor growth.

Keytruda approved as a first-line treatment for non-small cell lung cancer.

Swedish study suggests that more American men can opt surveillance over prostate cancer treatment.

Astellaas Pharma has entered into an agreement to acquire Ganymed and its investigational cancer antibodies.

Triolimus contains paclitaxel plus 2 agents to prevent chemotherapy resistance.

Injections of nanoliposomes reversed memory loss associated with Alzheimer’s disease in mouse models.

Top news of the day from across the health care landscape.

Eli Lilly and Company will launch a revised version of a tool that tracks the progress of cancer over time.

A specific mark in histones speeds up repairs in cancer cells, increasing their resistance to treatment.

Top news of the day from across the health care landscape.

A novel approach looks to provide researchers with the tools to make accurate and safe predictions for cancer patients.

Ribociclib treats patients with HR+/HER2- advanced or metastatic breast cancer.

Experimental drug treats patients with HR+/HER2- advanced or metastatic breast cancer.

As symptoms of depression worsen, so too does the length of survival in lung cancer patients, according to a study published in the Journal of Clinical Oncology.

Fission yeast is a low cost and fast system that can improve the cancer drug discovery process.

Top news of the day from across the health care landscape.

A method to detect underwater structure damage could be used to detect breast cancer.

A drug used to treat kidney cancer could be effective fighting several types of the disease.

Only 58% of breast cancer survivors received follow-up mammograms in 2007.

Top news of the week in oncology and cancer drug development.

Researchers found a low-cost approach to examine individual cancer cells, which could lead to a breakthrough in treatments.

Debiopharm International joins the Merck-Pfizer alliance for non-small cell lung cancer treatment research.

A nonsteroid anti-inflammatory drug used to treat common colds blocks bladder cancer cells from spreading in mice.

Top news of the day from across the health care landscape.

Positive results in the KEYNOTE-045 clinical trial of Keytruda showed improved overall survival.